SCHEMBL7448063

SCHEMBL7448063

NC(=O)c1cnc2ccc(C(O)O)cc2n1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ TGFBR1 P36897 2/20 0.47
▸ HPGD P15428 2/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ GRM2 Q14416 6/20 0.36
▸ SIRT6 Q8N6T7 1/20 0.35
▸ LCK P06239 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ CHEK2 O96017 1/20 0.34
▸ PTK2 Q05397 1/20 0.34
▸ OGA O60502 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22280319 0.86 TGFBR1 (0.49) TGFBR1HPGDALDH1A1ALOX15HSD17B10
SCHEMBL851358 0.74 ALDH1A1 (0.69) TGFBR1HPGDALDH1A1ALOX15HSD17B10
SCHEMBL29540343 0.74 ALDH1A1 (0.69) TGFBR1HPGDALDH1A1ALOX15HSD17B10
SCHEMBL22955472 0.74 TGFBR1 (0.49) TGFBR1HPGDALDH1A1ALOX15HSD17B10
Hydrochloric Acid SCHEMBL29488564 0.73 ALDH1A1 (0.67) TGFBR1HPGDALDH1A1ALOX15HSD17B10
SCHEMBL22672598 0.72 ALDH1A1 (0.56) HPGDALDH1A1ALOX15HSD17B10NPC1
SCHEMBL31603641 0.71 TGFBR1 (0.43) TGFBR1HPGDALDH1A1ALOX15HSD17B10
SCHEMBL30310860 0.68 KMT2A (0.55) TGFBR1HPGDALDH1A1ALOX15HSD17B10
SCHEMBL18911366 0.67 ADORA3 (0.48) TGFBR1HPGDALDH1A1ALOX15HSD17B10
SCHEMBL23772187 0.66 TDP1 (0.59) HPGDALDH1A1KDM4ENPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1196397-A1 METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS AND THEIR USE FOR TREATING CENTRAL NERVOUS SYSTEM DISEASES NPS PHARMACEUTICALS, INC. (US) 2002-04-17 — — EP disclosed
WO-2000073283-A1 METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS AND THEIR USE FOR TREATING CENTRAL NERVOUS SYSTEM DISEASES NPS PHARMACEUTICALS, INC. (US) 2000-12-07 — — WO disclosed
Send feedback